BlackRock Advisors’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
Other funds holding EW
BIT
BFA
BlackRock Advisors's EW Position: Q4 2016 in Review
BlackRock Advisors reduced its Edwards Lifesciences (EW) stake by 62% in Q4 2016, selling an estimated $73.3M and leaving 1,375,401 shares worth $43M. The position accounts for 0.04% of the portfolio, ranked #344.
BlackRock Advisors first reported a position in EW in Q2 2013 and has held it in 15 quarters since. The position peaked at $146M in Q3 2016. 686 funds tracked by Wall St. Rank hold EW as of Q4 2016.
- BlackRock Advisors held 1,375,401 shares of Edwards Lifesciences worth $43M as of Q4 2016.
- BlackRock Advisors sold 2,261,793 Edwards Lifesciences shares in Q4 2016, an estimated $73.3M.
- Edwards Lifesciences made up 0.04% of BlackRock Advisors's portfolio in Q4 2016, its #344 holding.
- BlackRock Advisors first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 15 quarters since.
- BlackRock Advisors's Edwards Lifesciences position peaked at $146M in Q3 2016.
- 686 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q4 2016.
Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.